TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
40,997
|
445,830
|
366,709 |
| Financial expenses |
97,852
|
115,841
|
58,989 |
| Earnings before taxes |
-422,829
|
-172,356
|
-95,369 |
| EBITDA |
-62,195
|
22,394
|
18,786 |
| Total assets |
1,940,941
|
1,961,619
|
1,874,133 |
| Current assets |
212,544
|
442,937
|
649,377 |
| Current liabilities |
361,997
|
351,480
|
257,578 |
| Equity capital |
721,105
|
579,927
|
742,845 |
| - share capital |
87,158
|
87,158
|
87,158 |
| Employees (average) |
45
|
115
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
37.2%
|
29.6%
|
39.6% |
| Turnover per employee |
911
|
3,877
|
3,492 |
| Profit as a percentage of turnover |
-1031.4%
|
-38.7%
|
-26.0% |
| Return on assets (ROA) |
-16.7%
|
-2.9%
|
-1.9% |
| Current ratio |
58.7%
|
126.0%
|
252.1% |
| Return on equity (ROE) |
-58.6%
|
-29.7%
|
-12.8% |
| Change turnover | |||
| Change turnover % |
22%
|
-7% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
10%
|
-4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.